AAM
TWST icon

Azzad Asset Management’s Twist Bioscience TWST Stock Holding History

Azzad Asset Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$233K Buy
+2,264
New +$147K 0.02% 340

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Azzad Asset Management's TWST Position: Q2 2026 in Review

Azzad Asset Management opened a new position in Twist Bioscience (TWST) in Q2 2026: 2,264 shares worth $233K. The stake represents 0.02% of the portfolio and ranks #340 among its holdings.

335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Azzad Asset Management held 2,264 shares of Twist Bioscience worth $233K as of Q2 2026.
  • Twist Bioscience was a new Azzad Asset Management position in Q2 2026.
  • Twist Bioscience made up 0.02% of Azzad Asset Management's portfolio in Q2 2026, its #340 holding.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Azzad Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.